[271]
Population-based fecal occult blood screening for colon cancer ...
[200,4 KB]
From [www.cmaj.ca] Last viewed: 07.09.2006
for colorectal cancer screening by the
recognized scientific bodies, and is not
paid for by Medicare or private insurers.
Any patients who anticipate trying
this technique would probably want
to assure that the newer 3-D imaging
using multi-slice scanning is used,
rather than the more readily available
but less reliable 2-D equipment.
• The risks related to radiation with
CT colonography remain uncertain.
Fecal DNA Testing: This test involves
collection of a stool sample at home that
is mailed to a central laboratory. The
laboratory checks for abnormal DNA
shed from the surface of colon cancers
and polyps.
• The test detects 52% of
colon cancers and 15% of
large polyps. If negative
it is repeated every 3 to 5
years. This test is better
than a stool blood test but
much more expensive.
Fecal DNA testing is
not nearly as effective as
...
[272]
G protein-coupled lysophosphatidic acid receptors stimulate ...
From [stke.sciencemag.org] Last viewed: 07.09.2006
for colorectal cancer screening by the
recognized scientific bodies, and is not
paid for by Medicare or private insurers.
Any patients who anticipate trying
this technique would probably want
to assure that the newer 3-D imaging
using multi-slice scanning is used,
rather than the more readily available
but less reliable 2-D equipment.
• The risks related to radiation with
CT colonography remain uncertain.
Fecal DNA Testing: This test involves
collection of a stool sample at home that
is mailed to a central laboratory. The
laboratory checks for abnormal DNA
shed from the surface of colon cancers
and polyps.
• The test detects 52% of
colon cancers and 15% of
large polyps. If negative
it is repeated every 3 to 5
years. This test is better
than a stool blood test but
much more expensive.
Fecal DNA testing is
not nearly as effective as
...
[273]
Vascular Endothelial Growth Factor in Human Colon Cancer: Biology ...
[576,3 KB]
From [theoncologist.alphamedpress.org] Last viewed: 07.09.2006
for colorectal cancer screening by the
recognized scientific bodies, and is not
paid for by Medicare or private insurers.
Any patients who anticipate trying
this technique would probably want
to assure that the newer 3-D imaging
using multi-slice scanning is used,
rather than the more readily available
but less reliable 2-D equipment.
• The risks related to radiation with
CT colonography remain uncertain.
Fecal DNA Testing: This test involves
collection of a stool sample at home that
is mailed to a central laboratory. The
laboratory checks for abnormal DNA
shed from the surface of colon cancers
and polyps.
• The test detects 52% of
colon cancers and 15% of
large polyps. If negative
it is repeated every 3 to 5
years. This test is better
than a stool blood test but
much more expensive.
Fecal DNA testing is
not nearly as effective as
...
[274]
Nonproteic Antioxidant Status in Plasma of Subjects with Colon Cancer
[145,9 KB]
From [www.ebmonline.org] Last viewed: 07.09.2006
for colorectal cancer screening by the
recognized scientific bodies, and is not
paid for by Medicare or private insurers.
Any patients who anticipate trying
this technique would probably want
to assure that the newer 3-D imaging
using multi-slice scanning is used,
rather than the more readily available
but less reliable 2-D equipment.
• The risks related to radiation with
CT colonography remain uncertain.
Fecal DNA Testing: This test involves
collection of a stool sample at home that
is mailed to a central laboratory. The
laboratory checks for abnormal DNA
shed from the surface of colon cancers
and polyps.
• The test detects 52% of
colon cancers and 15% of
large polyps. If negative
it is repeated every 3 to 5
years. This test is better
than a stool blood test but
much more expensive.
Fecal DNA testing is
not nearly as effective as
...
[275]
Assignment of the serologically defined colon cancer antigen 1 ...
[7,9 KB]
From [content.karger.com] Last viewed: 07.09.2006
45
Retinol inhibits the growth of
Retinoic Acid-resistant colon
cancer cells
Presenter
Jessica Leland
Collaborators
Professor Michelle Lane, Alice Dillard, and Erik Wilder, Department of
Human Ecology
Department
Nutrition
Abstract
Retinoids, derivatives of Vitamin A, are responsible for inducing differentiation and
inhibiting cell growth in colon cancer . Retinoic Acid (RA) is unable to inhibit the growth of
cells that become RA-resistant through alteration in metabolism or the loss of retinoic acid or
retinoic “X” receptor activity. We investigated the ability of the more physiologically
relevant retinoid, retinol, to inhibit the growth of RA-resistant colon cancer cell lines,
determined the bioactive metabolites produced within these cells, and the mechanism by
which growth is inhibited. HCT-116, SW620, and WiDr cells were treated with 0 (control),
...
[276]
The Src-Induced Mesenchymal State in Late-Stage Colon Cancer Cells
[7,9 KB]
From [content.karger.com] Last viewed: 07.09.2006
45
Retinol inhibits the growth of
Retinoic Acid-resistant colon
cancer cells
Presenter
Jessica Leland
Collaborators
Professor Michelle Lane, Alice Dillard, and Erik Wilder, Department of
Human Ecology
Department
Nutrition
Abstract
Retinoids, derivatives of Vitamin A, are responsible for inducing differentiation and
inhibiting cell growth in colon cancer . Retinoic Acid (RA) is unable to inhibit the growth of
cells that become RA-resistant through alteration in metabolism or the loss of retinoic acid or
retinoic “X” receptor activity. We investigated the ability of the more physiologically
relevant retinoid, retinol, to inhibit the growth of RA-resistant colon cancer cell lines,
determined the bioactive metabolites produced within these cells, and the mechanism by
which growth is inhibited. HCT-116, SW620, and WiDr cells were treated with 0 (control),
...
[277]
Polymyositis Successfully Treated with Surgical Resection of Colon ...
[7,9 KB]
From [content.karger.com] Last viewed: 07.09.2006
45
Retinol inhibits the growth of
Retinoic Acid-resistant colon
cancer cells
Presenter
Jessica Leland
Collaborators
Professor Michelle Lane, Alice Dillard, and Erik Wilder, Department of
Human Ecology
Department
Nutrition
Abstract
Retinoids, derivatives of Vitamin A, are responsible for inducing differentiation and
inhibiting cell growth in colon cancer . Retinoic Acid (RA) is unable to inhibit the growth of
cells that become RA-resistant through alteration in metabolism or the loss of retinoic acid or
retinoic “X” receptor activity. We investigated the ability of the more physiologically
relevant retinoid, retinol, to inhibit the growth of RA-resistant colon cancer cell lines,
determined the bioactive metabolites produced within these cells, and the mechanism by
which growth is inhibited. HCT-116, SW620, and WiDr cells were treated with 0 (control),
...
[278]
Adjuvant Therapy with Edrecolomab versus Observation in Stage II ...
[7,9 KB]
From [content.karger.com] Last viewed: 07.09.2006
45
Retinol inhibits the growth of
Retinoic Acid-resistant colon
cancer cells
Presenter
Jessica Leland
Collaborators
Professor Michelle Lane, Alice Dillard, and Erik Wilder, Department of
Human Ecology
Department
Nutrition
Abstract
Retinoids, derivatives of Vitamin A, are responsible for inducing differentiation and
inhibiting cell growth in colon cancer . Retinoic Acid (RA) is unable to inhibit the growth of
cells that become RA-resistant through alteration in metabolism or the loss of retinoic acid or
retinoic “X” receptor activity. We investigated the ability of the more physiologically
relevant retinoid, retinol, to inhibit the growth of RA-resistant colon cancer cell lines,
determined the bioactive metabolites produced within these cells, and the mechanism by
which growth is inhibited. HCT-116, SW620, and WiDr cells were treated with 0 (control),
...
[279]
Circulating Insulin-like Growth Factor-I Levels Regulate Colon ...
[467,0 KB]
From [cancerres.aacrjournals.org] Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk
Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that
connects the small intestine to the rectum. Cancer can begin in any part of the colon , but
before cancer develops, changes usually occur in the organ’s lining. One change is a tissue
growth called a polyp, which is a benign growth that can become malignant (cancerous) over
time. Once detected, a polyp may be removed, preventing it from becoming cancerous.
Who is at risk?
• People over 50
• People with a personal history of colon or rectal cancer or chronic inflammatory
bowel disease
• People with a strong family history of colon or rectal cancer or polyps, or any type of
cancer
• People who are physically inactive
• People who eat high-fat, low-fiber diets
• Tobacco users
What are the symptoms?
• A change in bowel habits lasting for more ...
[280]
Four New Colon Cancer Susceptibility Loci, Scc6 to Scc9 in the Mouse
[111,8 KB]
From [cancerres.aacrjournals.org] Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk
Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that
connects the small intestine to the rectum. Cancer can begin in any part of the colon , but
before cancer develops, changes usually occur in the organ’s lining. One change is a tissue
growth called a polyp, which is a benign growth that can become malignant (cancerous) over
time. Once detected, a polyp may be removed, preventing it from becoming cancerous.
Who is at risk?
• People over 50
• People with a personal history of colon or rectal cancer or chronic inflammatory
bowel disease
• People with a strong family history of colon or rectal cancer or polyps, or any type of
cancer
• People who are physically inactive
• People who eat high-fat, low-fiber diets
• Tobacco users
What are the symptoms?
• A change in bowel habits lasting for more ...
[281]
Growth Inhibition of Human Colon Cancer Cells by Nitric Oxide (NO ...
[181,9 KB]
From [cancerres.aacrjournals.org] Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk
Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that
connects the small intestine to the rectum. Cancer can begin in any part of the colon , but
before cancer develops, changes usually occur in the organ’s lining. One change is a tissue
growth called a polyp, which is a benign growth that can become malignant (cancerous) over
time. Once detected, a polyp may be removed, preventing it from becoming cancerous.
Who is at risk?
• People over 50
• People with a personal history of colon or rectal cancer or chronic inflammatory
bowel disease
• People with a strong family history of colon or rectal cancer or polyps, or any type of
cancer
• People who are physically inactive
• People who eat high-fat, low-fiber diets
• Tobacco users
What are the symptoms?
• A change in bowel habits lasting for more ...
[282]
Counterpoint: From Animal Models to Prevention of Colon Cancer ...
[32,8 KB]
From [cebp.aacrjournals.org] Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk
Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that
connects the small intestine to the rectum. Cancer can begin in any part of the colon , but
before cancer develops, changes usually occur in the organ’s lining. One change is a tissue
growth called a polyp, which is a benign growth that can become malignant (cancerous) over
time. Once detected, a polyp may be removed, preventing it from becoming cancerous.
Who is at risk?
• People over 50
• People with a personal history of colon or rectal cancer or chronic inflammatory
bowel disease
• People with a strong family history of colon or rectal cancer or polyps, or any type of
cancer
• People who are physically inactive
• People who eat high-fat, low-fiber diets
• Tobacco users
What are the symptoms?
• A change in bowel habits lasting for more ...
[283]
Underreporting of Family History of Colon Cancer: Correlates and ...
[32,9 KB]
From [cebp.aacrjournals.org] Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk
Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that
connects the small intestine to the rectum. Cancer can begin in any part of the colon , but
before cancer develops, changes usually occur in the organ’s lining. One change is a tissue
growth called a polyp, which is a benign growth that can become malignant (cancerous) over
time. Once detected, a polyp may be removed, preventing it from becoming cancerous.
Who is at risk?
• People over 50
• People with a personal history of colon or rectal cancer or chronic inflammatory
bowel disease
• People with a strong family history of colon or rectal cancer or polyps, or any type of
cancer
• People who are physically inactive
• People who eat high-fat, low-fiber diets
• Tobacco users
What are the symptoms?
• A change in bowel habits lasting for more ...
[284]
Dietary Isothiocyanates as Confounding Factors in the Molecular ...
[339,8 KB]
From [cebp.aacrjournals.org] Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk
Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that
connects the small intestine to the rectum. Cancer can begin in any part of the colon , but
before cancer develops, changes usually occur in the organ’s lining. One change is a tissue
growth called a polyp, which is a benign growth that can become malignant (cancerous) over
time. Once detected, a polyp may be removed, preventing it from becoming cancerous.
Who is at risk?
• People over 50
• People with a personal history of colon or rectal cancer or chronic inflammatory
bowel disease
• People with a strong family history of colon or rectal cancer or polyps, or any type of
cancer
• People who are physically inactive
• People who eat high-fat, low-fiber diets
• Tobacco users
What are the symptoms?
• A change in bowel habits lasting for more ...
[285]
Constipation, Anthranoid Laxatives, Melanosis Coli, and Colon ...
[38,3 KB]
From [cebp.aacrjournals.org] Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk
Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that
connects the small intestine to the rectum. Cancer can begin in any part of the colon , but
before cancer develops, changes usually occur in the organ’s lining. One change is a tissue
growth called a polyp, which is a benign growth that can become malignant (cancerous) over
time. Once detected, a polyp may be removed, preventing it from becoming cancerous.
Who is at risk?
• People over 50
• People with a personal history of colon or rectal cancer or chronic inflammatory
bowel disease
• People with a strong family history of colon or rectal cancer or polyps, or any type of
cancer
• People who are physically inactive
• People who eat high-fat, low-fiber diets
• Tobacco users
What are the symptoms?
• A change in bowel habits lasting for more ...
[286]
Levels of Colorectal Ornithine Decarboxylase Activity in Patients ...
[693,0 KB]
From [cebp.aacrjournals.org] Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk
Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that
connects the small intestine to the rectum. Cancer can begin in any part of the colon , but
before cancer develops, changes usually occur in the organ’s lining. One change is a tissue
growth called a polyp, which is a benign growth that can become malignant (cancerous) over
time. Once detected, a polyp may be removed, preventing it from becoming cancerous.
Who is at risk?
• People over 50
• People with a personal history of colon or rectal cancer or chronic inflammatory
bowel disease
• People with a strong family history of colon or rectal cancer or polyps, or any type of
cancer
• People who are physically inactive
• People who eat high-fat, low-fiber diets
• Tobacco users
What are the symptoms?
• A change in bowel habits lasting for more ...
[287]
Microsatellite Instability in Sporadic Colon Cancer Is Associated ...
[356,6 KB]
From [cebp.aacrjournals.org] Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk
Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that
connects the small intestine to the rectum. Cancer can begin in any part of the colon , but
before cancer develops, changes usually occur in the organ’s lining. One change is a tissue
growth called a polyp, which is a benign growth that can become malignant (cancerous) over
time. Once detected, a polyp may be removed, preventing it from becoming cancerous.
Who is at risk?
• People over 50
• People with a personal history of colon or rectal cancer or chronic inflammatory
bowel disease
• People with a strong family history of colon or rectal cancer or polyps, or any type of
cancer
• People who are physically inactive
• People who eat high-fat, low-fiber diets
• Tobacco users
What are the symptoms?
• A change in bowel habits lasting for more ...
[288]
Early Adulthood Physical Activity and Colon Cancer Risk among ...
[675,2 KB]
From [cebp.aacrjournals.org] Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk
Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that
connects the small intestine to the rectum. Cancer can begin in any part of the colon , but
before cancer develops, changes usually occur in the organ’s lining. One change is a tissue
growth called a polyp, which is a benign growth that can become malignant (cancerous) over
time. Once detected, a polyp may be removed, preventing it from becoming cancerous.
Who is at risk?
• People over 50
• People with a personal history of colon or rectal cancer or chronic inflammatory
bowel disease
• People with a strong family history of colon or rectal cancer or polyps, or any type of
cancer
• People who are physically inactive
• People who eat high-fat, low-fiber diets
• Tobacco users
What are the symptoms?
• A change in bowel habits lasting for more ...
[289]
Attitudes toward Colon Cancer Gene Testing: Survey of Relatives of ...
[183,0 KB]
From [cebp.aacrjournals.org] Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk
Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that
connects the small intestine to the rectum. Cancer can begin in any part of the colon , but
before cancer develops, changes usually occur in the organ’s lining. One change is a tissue
growth called a polyp, which is a benign growth that can become malignant (cancerous) over
time. Once detected, a polyp may be removed, preventing it from becoming cancerous.
Who is at risk?
• People over 50
• People with a personal history of colon or rectal cancer or chronic inflammatory
bowel disease
• People with a strong family history of colon or rectal cancer or polyps, or any type of
cancer
• People who are physically inactive
• People who eat high-fat, low-fiber diets
• Tobacco users
What are the symptoms?
• A change in bowel habits lasting for more ...
[290]
Decisional Consideration of Hereditary Colon Cancer Genetic Test ...
[49,0 KB]
From [cebp.aacrjournals.org] Last viewed: 07.09.2006
Colon Cancer :It’sTime to Talk
Colorectal cancer begins in the colon or rectum. The colon is a long muscular tube that
connects the small intestine to the rectum. Cancer can begin in any part of the colon , but
before cancer develops, changes usually occur in the organ’s lining. One change is a tissue
growth called a polyp, which is a benign growth that can become malignant (cancerous) over
time. Once detected, a polyp may be removed, preventing it from becoming cancerous.
Who is at risk?
• People over 50
• People with a personal history of colon or rectal cancer or chronic inflammatory
bowel disease
• People with a strong family history of colon or rectal cancer or polyps, or any type of
cancer
• People who are physically inactive
• People who eat high-fat, low-fiber diets
• Tobacco users
What are the symptoms?
• A change in bowel habits lasting for more ...
[291]
No association between colon cancer and adenocarcinoma of the ...
[111,4 KB]
From [gut.bmjjournals.com] Last viewed: 07.09.2006
for colorectal cancer screening by the
recognized scientific bodies, and is not
paid for by Medicare or private insurers.
Any patients who anticipate trying
this technique would probably want
to assure that the newer 3-D imaging
using multi-slice scanning is used,
rather than the more readily available
but less reliable 2-D equipment.
• The risks related to radiation with
CT colonography remain uncertain.
Fecal DNA Testing: This test involves
collection of a stool sample at home that
is mailed to a central laboratory. The
laboratory checks for abnormal DNA
shed from the surface of colon cancers
and polyps.
• The test detects 52% of
colon cancers and 15% of
large polyps. If negative
it is repeated every 3 to 5
years. This test is better
than a stool blood test but
much more expensive.
Fecal DNA testing is
not nearly as effective as
...
[292]
Anti-p53 Autoantibodies in Colon Cancer Patients
From [www.annalsnyas.org] Last viewed: 07.09.2006
1
IN THIS ISSUE:
s
Medicinal Plant Research, p. 2
s
Studies Need Participants, p. 3
s
Mothers With Cancer , p. 2
s
People on the Move,p.3
s
Streaming Video Server, p. 3
s
Calendar, p. 4
Thomas Boyer, M.D., Director of
New Arizona Liver Institute
Arizona Cancer Center Receives
$17 Million Grant for
Colon Cancer Prevention Research
Arizona Cancer Center researchers have received more
than $17 million — the largest single grant to the UA
College of Medicine in the past five years — from the
National Cancer Institute to support colon cancer preven-
tion research. The grant will fund the work of a team of
researchers from six major universities over the next five
years.
“This grant will support the
efforts of a team of outstanding
cancer researchers who have ...
[293]
n their analysis of 2 studies of colon cancer screen- ing ...
From [archinte.ama-assn.org] Last viewed: 07.09.2006
1
IN THIS ISSUE:
s
Medicinal Plant Research, p. 2
s
Studies Need Participants, p. 3
s
Mothers With Cancer , p. 2
s
People on the Move,p.3
s
Streaming Video Server, p. 3
s
Calendar, p. 4
Thomas Boyer, M.D., Director of
New Arizona Liver Institute
Arizona Cancer Center Receives
$17 Million Grant for
Colon Cancer Prevention Research
Arizona Cancer Center researchers have received more
than $17 million — the largest single grant to the UA
College of Medicine in the past five years — from the
National Cancer Institute to support colon cancer preven-
tion research. The grant will fund the work of a team of
researchers from six major universities over the next five
years.
“This grant will support the
efforts of a team of outstanding
cancer researchers who have ...
[294]
Apoptosis in Cultured Human Colon Cancer Cells Induced by Combined ...
[732,7 KB]
From [jjco.oxfordjournals.org] Last viewed: 07.09.2006
1
IN THIS ISSUE:
s
Medicinal Plant Research, p. 2
s
Studies Need Participants, p. 3
s
Mothers With Cancer , p. 2
s
People on the Move,p.3
s
Streaming Video Server, p. 3
s
Calendar, p. 4
Thomas Boyer, M.D., Director of
New Arizona Liver Institute
Arizona Cancer Center Receives
$17 Million Grant for
Colon Cancer Prevention Research
Arizona Cancer Center researchers have received more
than $17 million — the largest single grant to the UA
College of Medicine in the past five years — from the
National Cancer Institute to support colon cancer preven-
tion research. The grant will fund the work of a team of
researchers from six major universities over the next five
years.
“This grant will support the
efforts of a team of outstanding
cancer researchers who have ...
[295]
An Orthotopic Mouse Model of Remetastasis of Human Colon Cancer ...
[306,3 KB]
From [clincancerres.aacrjournals.org] Last viewed: 07.09.2006
676 N
ORTH
S
T
. C
LAIR
, S
UITE
1200
C
HICAGO
, I
LLINOIS
60611-3013
(312) 695-1300
Contact: Amanda Widtfeldt
awidtfel@nmh.org
312-926-2955
Northwestern Memorial Hospital
Northwestern's cancer genetics program ID's gene variant that
increases colon cancer risk
CHICAGO – A paper published in this week's Journal of Clinical Oncology says Transforming
Growth Factor Beta Receptor 1*6A (TGFBR1*6A) – a mutated gene present in nearly one in
eight people and the most commonly inherited cancer susceptibility gene identified so far –
might be responsible for a significant proportion of familial colorectal cancers. The study,
published by researchers at Northwestern Memorial Hospital and Northwestern University's
Robert H. Lurie Comprehensive Cancer Center, says 15 to 20 percent ...
[296]
Expression of Uncoupling Protein-2 in Human Colon Cancer
[186,7 KB]
From [clincancerres.aacrjournals.org] Last viewed: 07.09.2006
676 N
ORTH
S
T
. C
LAIR
, S
UITE
1200
C
HICAGO
, I
LLINOIS
60611-3013
(312) 695-1300
Contact: Amanda Widtfeldt
awidtfel@nmh.org
312-926-2955
Northwestern Memorial Hospital
Northwestern's cancer genetics program ID's gene variant that
increases colon cancer risk
CHICAGO – A paper published in this week's Journal of Clinical Oncology says Transforming
Growth Factor Beta Receptor 1*6A (TGFBR1*6A) – a mutated gene present in nearly one in
eight people and the most commonly inherited cancer susceptibility gene identified so far –
might be responsible for a significant proportion of familial colorectal cancers. The study,
published by researchers at Northwestern Memorial Hospital and Northwestern University's
Robert H. Lurie Comprehensive Cancer Center, says 15 to 20 percent ...
[297]
Thymidylate Synthase Expression Correlates Closely with E2F1 ...
[50,6 KB]
From [clincancerres.aacrjournals.org] Last viewed: 07.09.2006
676 N
ORTH
S
T
. C
LAIR
, S
UITE
1200
C
HICAGO
, I
LLINOIS
60611-3013
(312) 695-1300
Contact: Amanda Widtfeldt
awidtfel@nmh.org
312-926-2955
Northwestern Memorial Hospital
Northwestern's cancer genetics program ID's gene variant that
increases colon cancer risk
CHICAGO – A paper published in this week's Journal of Clinical Oncology says Transforming
Growth Factor Beta Receptor 1*6A (TGFBR1*6A) – a mutated gene present in nearly one in
eight people and the most commonly inherited cancer susceptibility gene identified so far –
might be responsible for a significant proportion of familial colorectal cancers. The study,
published by researchers at Northwestern Memorial Hospital and Northwestern University's
Robert H. Lurie Comprehensive Cancer Center, says 15 to 20 percent ...
[298]
Thymidylate Synthase Protein Expression in Advanced Colon Cancer ...
[24,5 KB]
From [clincancerres.aacrjournals.org] Last viewed: 07.09.2006
676 N
ORTH
S
T
. C
LAIR
, S
UITE
1200
C
HICAGO
, I
LLINOIS
60611-3013
(312) 695-1300
Contact: Amanda Widtfeldt
awidtfel@nmh.org
312-926-2955
Northwestern Memorial Hospital
Northwestern's cancer genetics program ID's gene variant that
increases colon cancer risk
CHICAGO – A paper published in this week's Journal of Clinical Oncology says Transforming
Growth Factor Beta Receptor 1*6A (TGFBR1*6A) – a mutated gene present in nearly one in
eight people and the most commonly inherited cancer susceptibility gene identified so far –
might be responsible for a significant proportion of familial colorectal cancers. The study,
published by researchers at Northwestern Memorial Hospital and Northwestern University's
Robert H. Lurie Comprehensive Cancer Center, says 15 to 20 percent ...
[299]
Nuclear Matrix Protein Alterations Associated with Colon Cancer ...
[313,4 KB]
From [clincancerres.aacrjournals.org] Last viewed: 07.09.2006
676 N
ORTH
S
T
. C
LAIR
, S
UITE
1200
C
HICAGO
, I
LLINOIS
60611-3013
(312) 695-1300
Contact: Amanda Widtfeldt
awidtfel@nmh.org
312-926-2955
Northwestern Memorial Hospital
Northwestern's cancer genetics program ID's gene variant that
increases colon cancer risk
CHICAGO – A paper published in this week's Journal of Clinical Oncology says Transforming
Growth Factor Beta Receptor 1*6A (TGFBR1*6A) – a mutated gene present in nearly one in
eight people and the most commonly inherited cancer susceptibility gene identified so far –
might be responsible for a significant proportion of familial colorectal cancers. The study,
published by researchers at Northwestern Memorial Hospital and Northwestern University's
Robert H. Lurie Comprehensive Cancer Center, says 15 to 20 percent ...
[300]
Peanut lectin-induced proliferation of HT29 colon cancer cells is ...
From [glycob.oxfordjournals.org] Last viewed: 07.09.2006
What
You
Need
To
Know
About
Cancer
of the
Colon
and
Rectum
U.S. DEPARTMENT OF HEALTH
AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute
™
What
You
Need
To
Know
About
Index
Page 2
This booklet is about colon and rectal
cancer . The Cancer Information Service
can help you learn more about this
disease. The staff can talk with you in
English or Spanish.
The number is 1–800–4– CANCER
(1–800–422–6237). The number for
deaf and hard of hearing callers with
TTY equipment is 1–800–332–8615.
The call is free.
Este folleto es acerca del cáncer de
colon y recto. Llame al Servicio de
Información sobre el Cáncer para saber
más sobre esta enfermedad. Este servicio
tiene personal que habla español.
...